Tecnologie

 

NANOEMULSION DELIVERY SYSTEM (NeDS)

PCT IB2009/055754 (US PATENT ISSUED)

THE MAJOR CHALLENGE IN DEVELOPING A PRODUCT:
ACTIVE INGREDIENTS SOLUBILITY

Most of vegetal or synthetic small molecules are characterized by a high hydrophobicity, which causes poor affinity for biological membranes and insufficient bioavailability. When molecules are not able to solubilize, they are not absorbed by the systemic circulation and do not exert their activity.

OUR SOLUTION IS

A PATENTED TECHNOLOGICAL SYSTEM CONSTITUTED BY A PARTICULAR POLL OF EXCIPIENTS THAT HAS BEEN STUDIED TO:

DELIVER INSOLUBLE SUBSTANCES IN AQUEOUS SOLUTIONS

DELIVER AND IMPROVE THE ABSORPTION OF HYDROPHOBIC AND INSOLUBLE SUBSTANCES BY THE SUBLINGUAL CIRCULATION

THE TECHNOLOGY BEHIND NeDS

Nanoemulsions are molecular colloidal dispersions, which have an average diameter between 50 and 300 nm. In particular, Labomar nanoemulsions have an average diameter ranging from 100 to 300 nm.

EMULSIONS

NANOEMULSIONS

PHARMACEUTICAL FORM

SUBLINGUAL ORAL SPRAY

Thanks to this kind pf pharmaceutical form, the effect of the first passage through the liver is bypassed due to the faster and more complete absorption guaranteed by the widely-vascularized sublingual mucosa.

WIDE VASCULARIZATION


ENHANCED BIOAVAILABILITY

CLINICAL DATA

VITAMIN D3 ABSORPTION BY INTRAORAL (SPRAY) AND PERORAL (CAPSULES) DELIVERY IN HEALTHY SUBJECTS IN PATIENTS WITH MALABSORPTION SYNDROMES

BIOAVAILABILITY OF A NEW ORAL MELATONIN EMULSION SPRAY COMPARED WITH A STANDARD ORAL FORMULATION ON HEALTHY VOLUNTEERS

MAIN ADVANTAGES

DELIVERY OF LIPOPHILIC ACTIVE INGREDIENTS

HIGH BIOAVAILABILITY

HIGH SPEED ACTION

CAPTIVATING PHARMACEUTICAL FORM